141 related articles for article (PubMed ID: 37607867)
21. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
Bardet M; Unterreiner A; Malinverni C; Lafossas F; Vedrine C; Boesch D; Kolb Y; Kaiser D; Glück A; Schneider MA; Katopodis A; Renatus M; Simic O; Schlapbach A; Quancard J; Régnier CH; Bold G; Pissot-Soldermann C; Carballido JM; Kovarik J; Calzascia T; Bornancin F
Immunol Cell Biol; 2018 Jan; 96(1):81-99. PubMed ID: 29359407
[TBL] [Abstract][Full Text] [Related]
22. MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.
Baens M; Bonsignore L; Somers R; Vanderheydt C; Weeks SD; Gunnarsson J; Nilsson E; Roth RG; Thome M; Marynen P
PLoS One; 2014; 9(8):e103774. PubMed ID: 25105596
[TBL] [Abstract][Full Text] [Related]
23. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.
Hailfinger S; Lenz G; Ngo V; Posvitz-Fejfar A; Rebeaud F; Guzzardi M; Penas EM; Dierlamm J; Chan WC; Staudt LM; Thome M
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19946-51. PubMed ID: 19897720
[TBL] [Abstract][Full Text] [Related]
24. MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.
Schmitt A; Grondona P; Maier T; Brändle M; Schönfeld C; Jäger G; Kosnopfel C; Eberle FC; Schittek B; Schulze-Osthoff K; Yazdi AS; Hailfinger S
J Invest Dermatol; 2016 Apr; 136(4):788-797. PubMed ID: 26767426
[TBL] [Abstract][Full Text] [Related]
25. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
[TBL] [Abstract][Full Text] [Related]
26. Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-
Liang X; Yu H; Liang R; Feng Z; Saidahmatov A; Sun C; Ren H; Wei X; Zhao J; Yang C; Liu H
J Med Chem; 2024 Feb; 67(4):2884-2906. PubMed ID: 38349664
[TBL] [Abstract][Full Text] [Related]
27. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
28. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M
EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.
Wittner L; Wagener L; Wiese JJ; Stolzer I; Krug SM; Naschberger E; Jackstadt R; Beyaert R; Atreya R; Kühl AA; Sturm G; Gonzalez-Acera M; Patankar JV; Becker C; Siegmund B; Trajanoski Z; Winner B; Neurath MF; Schumann M; Günther C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108564
[TBL] [Abstract][Full Text] [Related]
30. Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.
Juilland M; Alouche N; Ubezzi I; Gonzalez M; Rashid HO; Scarpellino L; Erdmann T; Grau M; Lenz G; Luther SA; Thome M
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2301155120. PubMed ID: 38109544
[TBL] [Abstract][Full Text] [Related]
31. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
32. Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.
Zhang YY; Peng J; Luo XJ
Biochem Pharmacol; 2022 Apr; 198():114977. PubMed ID: 35218741
[TBL] [Abstract][Full Text] [Related]
33. Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas.
Eitelhuber AC; Vosyka O; Nagel D; Bognar M; Lenze D; Lammens K; Schlauderer F; Hlahla D; Hopfner KP; Lenz G; Hummel M; Verhelst SH; Krappmann D
Chem Biol; 2015 Jan; 22(1):129-38. PubMed ID: 25556945
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region.
Yu JW; Jeffrey PD; Ha JY; Yang X; Shi Y
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21004-9. PubMed ID: 22158899
[TBL] [Abstract][Full Text] [Related]
35. Assignment of IVL-Methyl side chain of the ligand-free monomeric human MALT1 paracaspase-IgL
Han X; Levkovets M; Lesovoy D; Sun R; Wallerstein J; Sandalova T; Agback T; Achour A; Agback P; Orekhov VY
Biomol NMR Assign; 2022 Oct; 16(2):363-371. PubMed ID: 36094731
[TBL] [Abstract][Full Text] [Related]
36. Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface.
Cabalzar K; Pelzer C; Wolf A; Lenz G; Iwaszkiewicz J; Zoete V; Hailfinger S; Thome M
PLoS One; 2013; 8(8):e72051. PubMed ID: 23977204
[TBL] [Abstract][Full Text] [Related]
37. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.
Fontan L; Yang C; Kabaleeswaran V; Volpon L; Osborne MJ; Beltran E; Garcia M; Cerchietti L; Shaknovich R; Yang SN; Fang F; Gascoyne RD; Martinez-Climent JA; Glickman JF; Borden K; Wu H; Melnick A
Cancer Cell; 2012 Dec; 22(6):812-24. PubMed ID: 23238016
[TBL] [Abstract][Full Text] [Related]
38. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
[TBL] [Abstract][Full Text] [Related]
39. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
[TBL] [Abstract][Full Text] [Related]
40. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]